PROGRAM
November 23, 2018 |
09:00 Introduction Ferdinando Cornelio, AIM President
Fabrizio Tagliavini, Scientific Director Foundation IRCCS “Carlo Besta”
Multiple Sclerosis
09:30 An EAE model established by C. Besta in 1906 - R. Mantegazza, Italy
10:00 EAE as a Translational Tool for MS - G. Martino, Italy
10:30 Genetics of MS - J. R. Oksenberg, USA
11:00 Coffee Break
11:30 MS Clinical Course and Outcome Measures - F. Piehl, Sweden
12:00 Neuroradiology of MS: past, present and future - M. Calabrese, Italy
12:30 Future perspective in the treatment of MS: Translation towards Patient-Centered approach - A. Miller, Israel
13:00 ----------------------------------
Lunch
Myasthenia Gravis and Related Disorders of the NMJ
14:30 Neurobiology of the NMJ - M. A. Ruegg, Switzerland
15:00 EAMG as a Translational Tool for MG - N. Lycke, Sweden
15:30 Thymus and autoimmunity in MG - P. Cavalcante, Italy
16:00 Coffee Break
16:30 Innovative Drugs in MG - J.F. Howard Jr., USA
17:00 LEMS - A. Kostera-Pruszczyk, Poland
17:30 Congenital Myasthenic Syndromes - L. Maggi, Italy
18:00 ----------------------------------
Fabrizio Tagliavini, Scientific Director Foundation IRCCS “Carlo Besta”
Multiple Sclerosis
09:30 An EAE model established by C. Besta in 1906 - R. Mantegazza, Italy
10:00 EAE as a Translational Tool for MS - G. Martino, Italy
10:30 Genetics of MS - J. R. Oksenberg, USA
11:00 Coffee Break
11:30 MS Clinical Course and Outcome Measures - F. Piehl, Sweden
12:00 Neuroradiology of MS: past, present and future - M. Calabrese, Italy
12:30 Future perspective in the treatment of MS: Translation towards Patient-Centered approach - A. Miller, Israel
13:00 ----------------------------------
Lunch
Myasthenia Gravis and Related Disorders of the NMJ
14:30 Neurobiology of the NMJ - M. A. Ruegg, Switzerland
15:00 EAMG as a Translational Tool for MG - N. Lycke, Sweden
15:30 Thymus and autoimmunity in MG - P. Cavalcante, Italy
16:00 Coffee Break
16:30 Innovative Drugs in MG - J.F. Howard Jr., USA
17:00 LEMS - A. Kostera-Pruszczyk, Poland
17:30 Congenital Myasthenic Syndromes - L. Maggi, Italy
18:00 ----------------------------------
November 24, 2018 |
Neuroimmunity and Neurodamage
09:30 EBV in CNS autoimmunity - F. Aloisi, Italy
10:00 Neuroinflammation and epilepsy - A. Vezzani. Italy
10:30 AQP4/MOG autoimmunity and Neurodamage - M. Bradl, Austria
11:00 Coffee Break
11:30 Neuroinflammation and damage in Neurodegenerative Diseases - S. Amor, The Netherlands
12:00 Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system - R. Martini, Germany
12:30 ----------------------------------
09:30 EBV in CNS autoimmunity - F. Aloisi, Italy
10:00 Neuroinflammation and epilepsy - A. Vezzani. Italy
10:30 AQP4/MOG autoimmunity and Neurodamage - M. Bradl, Austria
11:00 Coffee Break
11:30 Neuroinflammation and damage in Neurodegenerative Diseases - S. Amor, The Netherlands
12:00 Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system - R. Martini, Germany
12:30 ----------------------------------